Cash & Short-Term Investments

$435.80M

Quarterly · Period ending: Jun 30, 2026 · USD

WST Cash & Short-Term Investments

Latest reported$435.80Mperiod endingJun 30, 2026

WST Quarterly Cash & Short-Term Investments ($8.50M → $435.80M)

Quarterly Cash & Short-Term Investments

High-resolution chart · PNG

WST cash & short-term investments history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

West Pharmaceutical Services Cash & Short-Term Investments — Quarterly (USD)
Period ending	Cash & Short-Term Investments (USD)
Jun 30, 2026	435,800,000
Mar 31, 2026	521,400,000
Dec 31, 2025	791,300,000
Sep 30, 2025	628,500,000
Jun 30, 2025	509,700,000
Mar 31, 2025	404,200,000
Dec 31, 2024	484,600,000
Sep 30, 2024	490,900,000
Jun 30, 2024	446,200,000
Mar 31, 2024	601,800,000
Dec 31, 2023	853,900,000
Sep 30, 2023	898,600,000
Jun 30, 2023	796,300,000
Mar 31, 2023	886,300,000
Dec 31, 2022	894,300,000
Sep 30, 2022	729,000,000
Jun 30, 2022	718,500,000
Mar 31, 2022	667,700,000
Dec 31, 2021	762,600,000
Sep 30, 2021	688,000,000
Jun 30, 2021	576,200,000
Mar 31, 2021	483,700,000
Dec 31, 2020	615,500,000
Sep 30, 2020	519,400,000
Jun 30, 2020	445,900,000
Mar 31, 2020	335,300,000
Dec 31, 2019	439,100,000
Sep 30, 2019	396,000,000
Jun 30, 2019	326,700,000
Mar 31, 2019	265,500,000
Dec 31, 2018	337,400,000
Sep 30, 2018	297,300,000
Jun 30, 2018	225,500,000
Mar 31, 2018	199,800,000
Dec 31, 2017	235,900,000
Sep 30, 2017	269,300,000
Jun 30, 2017	226,600,000
Mar 31, 2017	169,400,000
Dec 31, 2016	203,000,000
Sep 30, 2016	205,900,000
Jun 30, 2016	202,700,000
Mar 31, 2016	178,100,000
Dec 31, 2015	274,600,000
Sep 30, 2015	256,800,000
Jun 30, 2015	252,000,000
Mar 31, 2015	207,100,000
Dec 31, 2014	255,300,000
Sep 30, 2014	246,800,000
Jun 30, 2014	226,700,000
Mar 31, 2014	230,000,000
Dec 31, 2013	237,500,000
Sep 30, 2013	229,200,000
Jun 30, 2013	198,100,000
Mar 31, 2013	183,200,000
Dec 31, 2012	174,300,000
Sep 30, 2012	165,100,000
Jun 30, 2012	132,500,000
Mar 31, 2012	126,600,000
Dec 31, 2011	91,800,000
Sep 30, 2011	119,200,000
Jun 30, 2011	110,400,000
Mar 31, 2011	94,600,000
Dec 31, 2010	110,200,000
Sep 30, 2010	97,100,000
Jun 30, 2010	67,500,000
Mar 31, 2010	65,900,000
Dec 31, 2009	83,100,000
Sep 30, 2009	79,500,000
Jun 30, 2009	86,900,000
Mar 31, 2009	65,600,000
Dec 31, 2008	91,500,000
Sep 30, 2008	108,500,000
Aug 5, 2008	112,000,000
Mar 31, 2008	106,500,000
Dec 31, 2007	129,400,000
Sep 30, 2007	151,400,000
Jun 30, 2007	177,300,000
Mar 31, 2007	156,600,000
Dec 31, 2006	47,100,000
Sep 30, 2006	44,800,000
Jun 30, 2006	46,100,000
Mar 31, 2006	31,300,000
Dec 31, 2005	48,800,000
Sep 30, 2005	20,900,000
Jun 30, 2005	61,500,000
Mar 31, 2005	54,000,000
Dec 31, 2004	68,800,000
Sep 30, 2004	63,300,000
Jun 30, 2004	52,900,000
Mar 31, 2004	124,300,000
Dec 31, 2003	37,800,000
Sep 30, 2003	54,500,000
Jun 30, 2003	44,300,000
Mar 31, 2003	37,100,000
Dec 31, 2002	33,200,000
Sep 30, 2002	35,700,000
Jun 30, 2002	28,000,000
Mar 31, 2002	28,900,000
Dec 31, 2001	42,100,000
Sep 30, 2001	41,600,000